The scale has said the same thing for three weeks, and a quiet dread is creeping in: is it over? Did the medication stop working? Did you do something wrong?
Almost certainly not, on all three counts. Plateaus on GLP-1 medications are so consistent across patients and clinical trials that they are best understood as a scheduled stop on the route, not a wrong turn. The real questions are subtler: is this actually a plateau or just noise, has anything drifted underneath it, and what should the conversation with your prescriber look like? All three are questions your own data can help answer, which is what this article is about.
Plateaus are physiology, not failure
Weight loss slows and eventually stalls on these medications for reasons that have nothing to do with willpower. As weight comes down, the body adapts: a smaller body burns fewer calories at rest and during movement, so the gap between energy in and energy out narrows even when eating habits stay exactly the same. Metabolic adaptation works alongside this, with the body defending itself against further loss. The deficit that produced steady losses in month two simply is not the same deficit by month ten.
The clinical trials reflect this arc. In the major semaglutide and tirzepatide studies, average weight loss flattened out somewhere around 60 to 68 weeks, after roughly a year and a quarter of decline. Individuals vary widely around that average, but the shape is universal: fast early, slower in the middle, flat eventually. A plateau is what arriving looks like on a chart.
That reframe matters practically, because the two instinctive responses to a stall, quietly giving up or quietly pushing the dose, are both wrong. The first throws away hard-won maintenance; the second is genuinely unsafe, and dose decisions are never yours or ours to make. The right response starts with a more boring question: is this even a plateau?
Trend versus noise: what three weeks of scale data really says
Daily weight is one of the noisiest numbers a person can measure. Hydration, salt, carbohydrate intake, hormonal cycles, bowel habits, even the time of your last meal can swing the scale by more than most weeks' true change. A single flat or upward week means very little; three identical Mondays mean less than they appear to.
This is where logged data earns its keep. A weight trend built from weeks of entries smooths daily spikes into a line, and lines are much harder to misread than mornings:
- A trend still drifting down through noisy daily bounces is not a plateau, no matter what any single weigh-in said. This describes a surprising share of "plateaus".
- A trend genuinely flat for four to six weeks or more is worth calling a plateau and worth discussing, calmly, at your next appointment.
- A trend that flattened right after a life change (new job, injury, vacation month) is pointing at the change, not the medication.
The rule of thumb: never diagnose a plateau from days. Weeks of trend, viewed as a line, are the minimum honest evidence. If you weigh daily, let the trend absorb the noise for you; if weighing daily makes you anxious, a couple of consistent weekly weigh-ins feed the same line more slowly.
GLP 1 Tracker AppWeight trends, doses, protein and activity in one free, private log. See the line, not the noise.
Get the app
The drift check: what else your logs know
Before a plateau conversation, it is worth auditing the quiet variables, because months of routine erode habits so gradually that nobody notices. Your logs did notice. Three places to look:
- Protein. Appetite suppression makes protein the first number to sag, and protein is what stands between weight loss and muscle loss. If your daily average has slid, that matters for body composition even when the scale is flat; our guide to protein goals on GLP-1s covers the commonly cited targets and why they exist.
- Activity. Steps and workouts drift down in winter, in busy seasons, in plateaus themselves (discouragement is sedentary). If you import steps and active energy from Apple Health, the answer is already in your history rather than your memory.
- Eating patterns. Not calorie forensics, just honesty: have portion sizes, snacks, or alcohol crept since month two? A light food log, kept even loosely, answers this better than recollection ever will.
Sometimes this audit finds real drift, which is genuinely good news: it means there is an obvious, non-pharmacological lever to discuss. Sometimes it finds nothing, which is also useful, because "everything held steady and the trend still flattened" is precisely the information a prescriber wants. Either way you walk in with facts. A flat scale can also coexist with quiet wins the scale cannot see, like inches, energy, and strength, which is worth remembering before declaring the whole project stalled. For the long-game view of tracking tirzepatide specifically, our Zepbound guide takes up the same theme.
The conversation with your prescriber
A plateau is a prescriber conversation, and it is a much better one when the data comes along. What helps them help you:
- Your weight trend over the last two to three months, as a chart rather than a recollection
- Where you are on the titration ladder and how long you have been at the current dose
- Your adherence record: any missed or late doses, straight from the log
- The drift check above: protein, activity, and eating patterns, with numbers where you have them
- Side effects, since tolerability shapes every option they might consider
What the prescriber does with this is their craft, not ours: options range from patience (often the right answer) to nutrition and training changes to medication decisions that are theirs alone to make. The app will never suggest a dose change, and neither will we; the entire job of your data is to make their judgment better informed. Our guide to bringing data to appointments covers how to compress months of logs into the first five minutes of a visit.
Living on the plateau
One more reframe, because it is the one that matters at week 60 and beyond: a plateau you maintain is not nothing. Holding a significantly lower weight steady, month after month, is the outcome the entire effort was pointed at, and it is active work your logs can honor even when the trend line is horizontal. Keep logging doses, protein, water and weight through the flat stretch; maintenance data is what proves the plateau is stable rather than the start of a rebound, and it keeps the routine alive for whatever comes next.
Plateaus are also where long history earns its keep. A stall only reads correctly against months of context, not weeks. In GLP 1 Tracker App the free tier keeps your last 30 days, which covers the day-to-day; Premium keeps unlimited history, which is the view a year-long arc, plateau included, actually needs.
The takeaway
Plateaus on GLP-1s are expected physiology with a well-documented timeline, not evidence that you or the medication failed. Before reacting to one: confirm it is real with weeks of trend rather than days of scale readings, audit protein, activity and eating for quiet drift, and then bring the whole picture to your prescriber and decide together. Your data cannot break a plateau. It can tell you, and them, exactly what kind of plateau you are standing on, and that is where every good next step begins.
Frequently asked questions
Is it normal to hit a weight loss plateau on Ozempic or Wegovy?
Yes. Plateaus on GLP-1 medications are expected physiology, not failure. As weight comes down, a smaller body burns fewer calories and metabolic adaptation narrows the deficit, so loss slows and eventually flattens even when habits stay exactly the same. In the major semaglutide and tirzepatide trials, average weight loss plateaued around 60 to 68 weeks. What to do about a plateau is a conversation for your prescriber.
How do I know if my weight loss has really plateaued?
Never diagnose a plateau from days. Daily weight swings with hydration, salt, hormones, and meals, so a flat week means little. Build a trend line from weeks of entries: a line still drifting down through noisy daily bounces is not a plateau, while a trend genuinely flat for four to six weeks or more is worth calling one, and worth discussing calmly at your next appointment.
What should I do when my GLP-1 weight loss stalls?
First confirm it is real with weeks of trend data. Then audit the quiet variables your logs already know: whether protein has sagged, whether steps and activity have drifted, whether portions or snacks have crept since month two. Bring the trend, your titration position, your adherence record, and side effects to your prescriber and decide together. Never adjust your dose on your own; dose decisions belong entirely to your prescriber.
Does hitting a plateau mean my GLP-1 stopped working?
Almost certainly not. Weight loss flattening after many months is the documented arc of these medications, and it reflects the body adapting rather than the drug failing. A plateau you maintain is not nothing: holding a significantly lower weight steady, month after month, is the outcome the whole effort was pointed at. If you are worried, bring your trend chart to your prescriber and talk it through.
Can an app help me see whether I have plateaued?
A trend view is exactly what separates a stall from noise. GLP 1 Tracker App keeps weight, doses, protein, water, and activity in one free, private log, with read-only imports from Apple Health for smart scale weight and steps. The free tier keeps your last 30 days; Premium keeps unlimited history, the view a year-long arc actually needs. The app never suggests dose changes; its job is making the prescriber conversation better informed.